
BioSig Technologies BSGM
Quarterly report 2025-Q3
added 11-14-2025
BioSig Technologies Total Liabilities 2011-2025 | BSGM
Annual Total Liabilities BioSig Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.26 M | 4.68 M | 3.71 M | 2.95 M | 5.11 M | 2.34 M | 1.2 M | 3.97 M | 2.96 M | 2.47 M | 1.23 M | 3.02 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.11 M | 1.2 M | 2.99 M |
Quarterly Total Liabilities BioSig Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 M | 113 M | 1.68 M | 2.26 M | 1.7 M | 2.99 M | 5.79 M | 4.68 M | 4.1 M | 3.61 M | 3.18 M | 3.71 M | 3.08 M | 2.51 M | 3.03 M | 2.95 M | 2.99 M | 3.4 M | 3.95 M | 5.11 M | 5.11 M | 5.11 M | 5.11 M | - | 1.59 M | 1.88 M | 1.24 M | 1.2 M | - | 1.2 M | 1.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 137 M | 1.2 M | 11.5 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
165 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.83 | -0.91 % | $ 133 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
2.79 B | $ 306.74 | -0.45 % | $ 8.65 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
InMode Ltd.
INMD
|
81.9 M | $ 14.35 | -1.1 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 0.99 | 7.52 % | $ 16 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 45.67 | 1.2 % | $ 6.8 K | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 128.62 | 2.52 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 91.86 | -0.78 % | $ 135 B | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
1.19 B | $ 63.33 | 0.92 % | $ 3.44 B | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.19 | 10.76 % | $ 119 M | ||
|
LENSAR
LNSR
|
47.7 M | $ 11.5 | -0.09 % | $ 132 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
PAVmed
PAVM
|
57.1 M | $ 0.31 | -4.88 % | $ 2.24 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
281 M | $ 9.6 | -2.64 % | $ 689 M | ||
|
Profound Medical Corp.
PROF
|
12.7 M | $ 7.74 | 5.53 % | $ 180 M | ||
|
Quanterix Corporation
QTRX
|
78.1 M | $ 7.5 | -0.86 % | $ 282 M | ||
|
IRadimed Corporation
IRMD
|
11.5 M | $ 97.18 | 0.99 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.36 B | $ 163.64 | -1.08 % | $ 12.3 B | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 1.05 | -0.94 % | $ 108 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
13.8 M | $ 12.52 | -1.49 % | $ 338 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 14.9 | 1.02 % | $ 97.7 M | ||
|
AxoGen
AXGN
|
99.8 M | $ 29.72 | -2.2 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
1.34 B | $ 40.32 | -1.26 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
119 M | $ 17.74 | 0.8 % | $ 409 M | ||
|
Globus Medical
GMED
|
1.07 B | $ 86.69 | - | $ 11.8 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 13.55 | 0.97 % | $ 1.04 B | ||
|
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M |